SimBioSys

SimBioSys

Champaign, United States· Est. 2017

Our visualization and diagnostic technology is designed to deliver precision answers to critical clinical questions, enabling clinicians to individualize patient treatment. The heterogeneous nature of tumors can lead to diverse responses to treatment across patients and regions of the same tumor. Our comprehensive approach addresses tumor heterogeneity by looking at the tumor in its entirety - beyond biopsies or 2D pathology slides.

Private Company

Total funding raised: $33M

About

Our visualization and diagnostic technology is designed to deliver precision answers to critical clinical questions, enabling clinicians to individualize patient treatment. The heterogeneous nature of tumors can lead to diverse responses to treatment across patients and regions of the same tumor. Our comprehensive approach addresses tumor heterogeneity by looking at the tumor in its entirety - beyond biopsies or 2D pathology slides.

AI / Machine LearningOncology

Funding History

3
Total raised:$33M
Series B$20MJul 15, 2022
Series A$10MFeb 15, 2020
Seed$3MMay 15, 2018